Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share (SNDX).
- Disclosed ownership: 2.7%.
- Date of event: 30 Jun 2025.
Point72 Asset Management, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share (SNDX)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- SNDX
- Shares outstanding
- 85,474,963 shares
- Disclosed Ownership
- 2,307,824 shares
- Ownership
- 2.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 17:39:50 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 22 Jan 2025
- Next filing
- 18 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 2.7% ownership in Syndax Pharmaceuticals Inc Common Stock, par value $0.0001 per share (SNDX) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 22 Jan 2025.
- Current filing was accepted on 14 Aug 2025, 17:39.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 2.7% | 2,307,824 | 0 | 2,307,824 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 2.7% | 2,307,824 | 0 | 2,307,824 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 2.7% | 2,307,824 | 0 | 2,307,824 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |